Comparative Pharmacology
Head-to-head clinical analysis: BENZYL BENZOATE versus EURAX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENZYL BENZOATE versus EURAX.
BENZYL BENZOATE vs EURAX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Benzyl benzoate is a scabicidal agent that disrupts the nervous system of mites by interacting with sodium channels, leading to paralysis and death.
Crotamiton exerts scabicidal and antipruritic effects by an unknown mechanism. It is thought to interfere with the nervous system of Sarcoptes scabiei, leading to mite death, and may also have a direct anti-inflammatory effect on the skin.
Apply 25% lotion or 10% cream to entire body (excluding face, scalp, and mucous membranes) once daily at bedtime for 2-5 days, or as a single 24-hour application; repeat after 7 days if needed. For scabies: 25% lotion applied from neck to toes, wash off after 24 hours; second application may be given at 1-week interval.
Apply topically as a 10% cream or lotion; massage thoroughly into skin from chin to toes, especially skin folds; leave on for 8-14 hours then wash off. Repeat in 7 days.
None Documented
None Documented
6-9 hours in plasma; clinical context: supports twice-daily application for scabies/lice
Terminal half-life is approximately 35-45 hours in adults, allowing for once-daily dosing in most indications.
Renal (excreted as hippuric acid and benzoic acid conjugates, ~75-90%); biliary/fecal (minor, ~10-25%)
Primarily renal (approximately 70% as unchanged drug and metabolites); biliary/fecal excretion accounts for about 20-30%.
Category C
Category C
Scabicide
Scabicide